Canada · Health Canada Drug Product Database
ROTATEQ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76999
- DIN
- 02284413
- Form
- Solution
- Company as listed by source
- MERCK CANADA INC
- Source status
- Marketed (2006-10-16)
- Source last updated
- 2026-08-06
Source-listed ingredients
- HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G1 — 2210000 UNIT — per 2 ML
- HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G2 — 2840000 UNIT — per 2 ML
- HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G3 — 2220000 UNIT — per 2 ML
- HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE G4 — 2040000 UNIT — per 2 ML
- HUMAN-BOVINE ROTAVIRUS REASSORTANT TYPE P1(8) — 2290000 UNIT — per 2 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 1x2ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →